Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10183928 Inhibitors of RET

Patent 10183928 was granted and assigned to Blueprint Medicines on January, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 24 Apr, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11964968 Compounds useful for inhibiting RET kinase
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11963958 RET inhibitor for use in treating cancer having a RET alteration
0
Edits on 19 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11872192 RET inhibitor for use in treating cancer having a RET alteration
0
Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article (+207 characters)
Article

Patent abstract

Described herein are compounds that inhibit wild-type RET and its resistant mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.

Edits on 2 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 2 Oct, 2023
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Jason D. Brubaker0
Joseph L. Kim0
Kevin J. Wilson0
Edits on 30 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 30 Apr, 2023
Edits on 28 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 28 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Blueprint Medicines
Blueprint Medicines
0
Current Assignee
Blueprint Medicines
Blueprint Medicines
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
101839280
Date of Patent
January 22, 2019
0
Patent Application Number
154622550
Date Filed
March 17, 2017
0
Patent Citations
‌
US Patent 10000490 Inhibitors of the fibroblast growth factor receptor
0
‌
US Patent 10000496 Compositions useful for treating disorders related to kit and PDGFR
0
‌
US Patent 10017512 Compounds and compositions useful for treating disorders related to NTRK
0
Patent Citations Received
‌
US Patent 10584114 Inhibitors of RET
0
‌
US Patent 10774070 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
0
‌
US Patent 10875837 Inhibitors of the fibroblast growth factor receptor
0
‌
US Patent 11273160 RET inhibitor for use in treating cancer having a RET alteration
0
‌
US Patent 11279688 Inhibitors of RET
0
Patent Primary Examiner
‌
Alexander R Pagano
0
Edits on 24 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2023
Infobox
Patent Citations Received
‌
US Patent 10584114 Inhibitors of RET
0
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2023
Edits on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Mar, 2023
Infobox
Patent Citations Received
‌
US Patent 11279688 Inhibitors of RET
0
Edits on 20 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 20 Mar, 2023
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 27 Sep, 2022
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Patent Citations Received
‌
US Patent 10584114 Inhibitors of RET
0
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 25 Sep, 2022
Edits on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Infobox
Patent Citations Received
‌
US Patent 11279688 Inhibitors of RET
0
Edits on 23 Mar, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 23 Mar, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11279688 Inhibitors of RET
Edits on 16 Mar, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 16 Mar, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11273160 RET inhibitor for use in treating cancer having a RET alteration
Edits on 8 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 8 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10875837 Inhibitors of the fibroblast growth factor receptor
Edits on 6 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 6 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10774070 2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors

Find more entities like US Patent 10183928 Inhibitors of RET

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo